Evidence map›Paper›PMID 37596354›Full record

ArticleMolecular psychiatry2023

Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5549 individuals.

Junya Matsumoto, Masaki Fukunaga, Kenichiro Miura, Kiyotaka Nemoto, Naohiro Okada, Naoki Hashimoto, Kentaro Morita, Daisuke Koshiyama, Kazutaka Ohi, Tsutomu Takahashi and 38 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Junya MatsumotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.ORCID 0000-0003-4228-3208
Masaki FukunagaSection of Brain Function Information, National Institute for Physiological Sciences, Okazaki, 444-8585, Japan.ORCID 0000-0003-1010-2644
Kenichiro MiuraDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.ORCID 0000-0002-3722-7837
Kiyotaka NemotoDepartment of Psychiatry, Institute of Medicine, University of Tsukuba, Tsukuba, 305-8575, Japan.ORCID 0000-0001-8623-9829
Naohiro OkadaDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Naoki HashimotoDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
Kentaro MoritaDepartment of Rehabilitation, University of Tokyo Hospital, Tokyo, 113-8655, Japan.
Daisuke KoshiyamaDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Kazutaka OhiDepartment of Psychiatry, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.ORCID 0000-0001-9577-9640
Tsutomu TakahashiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, 930-0194, Japan.ORCID 0000-0003-3213-6183
Michihiko KoedaDepartment of Neuropsychiatry, Graduate School of Medicine, Nippon Medical School, Tokyo, 113-8602, Japan.ORCID 0000-0003-3587-1845
Hidenaga YamamoriDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.
Michiko FujimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.
Yuka YasudaDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.
Satsuki ItoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.ORCID 0000-0003-4720-3166
Ryuichi YamazakiDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.
Naomi HasegawaDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan.
Hisashi NaritaDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.ORCID 0000-0003-0700-6600
Satoshi YokoyamaDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, 734-8551, Japan.ORCID 0000-0002-1309-1103
Ryo MishimaDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Jun MiyataDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.ORCID 0000-0003-1803-1975
Yuko KobayashiDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Daiki SasabayashiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, 930-0194, Japan.ORCID 0000-0001-8512-7438
Kenichiro HaradaDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, 755-8505, Japan.
Maeri YamamotoDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Yoji HiranoDepartment of Psychiatry, Division of Clinical Neuroscience, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan.
Takashi ItahashiMedical Institute of Developmental Disabilities Research, Showa University, Tokyo, 157-8577, Japan.
Masahito NakatakiDepartment of Psychiatry, Tokushima University Hospital, Tokushima, 770-8503, Japan.
Ryu-Ichiro HashimotoMedical Institute of Developmental Disabilities Research, Showa University, Tokyo, 157-8577, Japan.ORCID 0000-0002-9661-3412
Khin K ThaGlobal Center for Biomedical Science and Engineering, Hokkaido University Faculty of Medicine, Sapporo, 060-8638, Japan.ORCID 0000-0002-9072-4509
Shinsuke KoikeThe International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study (UTIAS), Tokyo, 113-0033, Japan.
Toshio MatsubaraDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, 755-8505, Japan.
Go OkadaDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Reiji YoshimuraDepartment of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Osamu AbeDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.ORCID 0000-0002-1180-2629
Theo G M van ErpClinical Translatational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, 92697, USA.
Jessica A TurnerDepartment of Psychiatry and Behavioral Health, Wexner Medical Center, the Ohio State University, Columbus, OH, 43210, USA.
Neda JahanshadImaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90292, USA.
Paul M ThompsonImaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90292, USA.
Toshiaki OnitsukaNational Hospital Organization Sakakibara Hospital, Tsu, 514-1292, Japan.
Yoshiyuki WatanabeDepartment of Radiology, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Koji MatsuoDepartment of Psychiatry, Faculty of Medicine, Saitama Medical University, Saitama, 350-0495, Japan.
Hidenori YamasueDepartment of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.ORCID 0000-0002-2748-6317
Yasumasa OkamotoDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Michio SuzukiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, 930-0194, Japan.
Norio OzakiPathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.ORCID 0000-0002-7360-4898
Kiyoto KasaiDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.ORCID 0000-0002-4443-4535
Ryota HashimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 187-8553, Japan. ryotahashimoto55@ncnp.go.jp.ORCID 0000-0002-5941-4238

Funding

ENIGMA-COINSTAC-APOE2 Functional and structural connectome protective mechanisms for Alzheimer’s disease and mood disorders: Request for supplemental funds for NIH R01:1R01MH121246R01MH121246 · NIMH · OHIO STATE UNIVERSITY · PI CALHOUN, VINCE D, TURNER, JESS · 2019 to 2023
$5.0M
Japan Agency for Medical Research and Development (AMED) JP18dm0307001Japan Agency for Medical Research and Development (AMED) JP18dm0307002Japan Agency for Medical Research and Development (AMED) JP18dm0307004Japan Agency for Medical Research and Development (AMED) JP18dm0307008Japan Agency for Medical Research and Development (AMED) JP19dm0207069Japan Agency for Medical Research and Development (AMED) JP21dk0307103Japan Agency for Medical Research and Development (AMED) JP21uk1024002Japan Agency for Medical Research and Development (AMED) JP21wm0425012MEXT | Japan Science and Technology Agency (JST) JPMJMS2021MEXT | Japan Society for the Promotion of Science (JSPS) JP17H04248MEXT | Japan Society for the Promotion of Science (JSPS) JP18H05130MEXT | Japan Society for the Promotion of Science (JSPS) JP19H05467MEXT | Japan Society for the Promotion of Science (JSPS) JP20H03605MEXT | Japan Society for the Promotion of Science (JSPS) JP20H03611MEXT | Japan Society for the Promotion of Science (JSPS) JP20H05064MEXT | Japan Society for the Promotion of Science (JSPS) JP20K06920MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05171MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05174MEXT | Japan Society for the Promotion of Science (JSPS) JP21K12153MEXT | Japan Society for the Promotion of Science (JSPS) JP22H04926MEXT | Japan Society for the Promotion of Science (JSPS) JP23K07001MEXT | Japan Society for the Promotion of Science (JSPS) JP26461767National Center of Neurology and Psychiatry (NCNP) 3-1National Center of Neurology and Psychiatry (NCNP) 4-6NIMH NIH HHS R01 MH121246
6 · The paper itself

Abstract

According to the operational diagnostic criteria, psychiatric disorders such as schizophrenia (SZ), bipolar disorder (BD), major depressive disorder (MDD), and autism spectrum disorder (ASD) are classified based on symptoms. While its cluster of symptoms defines each of these psychiatric disorders, there is also an overlap in symptoms between the disorders. We hypothesized that there are also similarities and differences in cortical structural neuroimaging features among these psychiatric disorders. T1-weighted magnetic resonance imaging scans were performed for 5,549 subjects recruited from 14 sites. Effect sizes were determined using a linear regression model within each protocol, and these effect sizes were meta-analyzed. The similarity of the differences in cortical thickness and surface area of each disorder group was calculated using cosine similarity, which was calculated from the effect sizes of each cortical regions. The thinnest cortex was found in SZ, followed by BD and MDD. The cosine similarity values between disorders were 0.943 for SZ and BD, 0.959 for SZ and MDD, and 0.943 for BD and MDD, which indicated that a common pattern of cortical thickness alterations was found among SZ, BD, and MDD. Additionally, a generally smaller cortical surface area was found in SZ and MDD than in BD, and the effect was larger in SZ. The cosine similarity values between disorders were 0.945 for SZ and MDD, 0.867 for SZ and ASD, and 0.811 for MDD and ASD, which indicated a common pattern of cortical surface area alterations among SZ, MDD, and ASD. Patterns of alterations in cortical thickness and surface area were revealed in the four major psychiatric disorders. To our knowledge, this is the first report of a cross-disorder analysis conducted on four major psychiatric disorders. Cross-disorder brain imaging research can help to advance our understanding of the pathogenesis of psychiatric disorders and common symptoms.

Indexed as

Autism Spectrum DisorderBipolar DisorderMajor Depressive DisorderMental DisordersCerebral CortexHumansMagnetic Resonance Imaging

Identifiers

PMID37596354
PMCPMC10914601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.